Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 104,661,494
- Total 13F shares
- 34,870,390
- Share change
- +653,682
- Total reported value
- $957,229,930
- Put/Call ratio
- 102%
- Price per share
- $27.45
- Number of holders
- 109
- Value change
- +$13,863,223
- Number of buys
- 62
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 761330109:
Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. |
13F
|
Company |
3.7%
|
3,842,047
|
$118,335,000 | — | 31 Mar 2018 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.6%
|
3,814,034
|
$117,472,000 | — | 31 Mar 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.3%
|
3,437,417
|
$105,872,000 | — | 31 Mar 2018 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3%
|
3,173,162
|
$97,733,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.3%
|
2,410,444
|
$74,243,000 | — | 31 Mar 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.9%
|
2,013,231
|
$62,007,000 | — | 31 Mar 2018 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.7%
|
1,735,699
|
$53,460,000 | — | 31 Mar 2018 | |
| NovaQuest Capital Management, L.L.C. |
13F
|
Company |
1.5%
|
1,558,426
|
$48,000,000 | — | 31 Mar 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,494,441
|
$46,029,000 | — | 31 Mar 2018 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.4%
|
1,483,037
|
$45,678,000 | — | 31 Mar 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
1,322,517
|
$40,734,000 | — | 31 Mar 2018 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.1%
|
1,139,111
|
$35,085,000 | — | 31 Mar 2018 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.59%
|
618,957
|
$19,064,000 | — | 31 Mar 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.57%
|
592,910
|
$18,259,000 | — | 31 Mar 2018 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.56%
|
582,900
|
$17,953,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
339,450
|
$10,455,000 | — | 31 Mar 2018 | |
| Fosun International Ltd |
13F
|
Company |
0.31%
|
319,313
|
$9,835,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
262,392
|
$8,081,000 | — | 31 Mar 2018 | |
| FMR LLC |
13F
|
Company |
0.23%
|
245,636
|
$7,566,000 | — | 31 Mar 2018 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.22%
|
228,086
|
$7,025,000 | — | 31 Mar 2018 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.19%
|
203,181
|
$6,258,000 | — | 31 Mar 2018 | |
| S.c.a. Candriam |
13F
|
Individual |
0.16%
|
171,000
|
$5,267,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
170,401
|
$5,248,000 | — | 31 Mar 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.16%
|
167,729
|
$5,165,000 | — | 31 Mar 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
149,900
|
$4,617,000 | — | 31 Mar 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
134,616
|
$4,147,000 | — | 31 Mar 2018 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.12%
|
126,020
|
$3,881,000 | — | 31 Mar 2018 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.11%
|
113,096
|
$3,483,000 | — | 31 Mar 2018 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.11%
|
111,360
|
$3,430,000 | — | 31 Mar 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
84,611
|
$2,606,000 | — | 31 Mar 2018 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.08%
|
83,700
|
$2,578,000 | — | 31 Mar 2018 | |
| Invesco Ltd. |
13F
|
Company |
0.08%
|
83,097
|
$2,559,000 | — | 31 Mar 2018 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.08%
|
79,959
|
$2,463,000 | — | 31 Mar 2018 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.08%
|
79,437
|
$2,447,000 | — | 31 Mar 2018 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.07%
|
72,849
|
$2,244,000 | — | 31 Mar 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.06%
|
67,235
|
$2,071,000 | — | 31 Mar 2018 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.06%
|
65,600
|
$2,020,000 | — | 31 Mar 2018 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.06%
|
63,900
|
$1,968,000 | — | 31 Mar 2018 | |
| QS Investors, LLC |
13F
|
Company |
0.06%
|
63,156
|
$1,945,000 | — | 31 Mar 2018 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.06%
|
62,545
|
$1,926,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
59,021
|
$1,818,000 | — | 31 Mar 2018 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.06%
|
58,530
|
$1,802,000 | — | 31 Mar 2018 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.05%
|
55,717
|
$1,717,000 | — | 31 Mar 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.05%
|
51,372
|
$1,582,000 | — | 31 Mar 2018 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
51,050
|
$1,572,000 | — | 31 Mar 2018 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
49,934
|
$1,538,000 | — | 31 Mar 2018 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.05%
|
49,645
|
$1,529,000 | — | 31 Mar 2018 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.05%
|
47,981
|
$1,478,000 | — | 31 Mar 2018 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
47,855
|
$1,474,000 | — | 31 Mar 2018 | |
| Global IMC LLC |
13F
|
Company |
0.04%
|
44,898
|
$1,383,000 | — | 31 Mar 2018 |
Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q2 2018
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.